Nature Communications · 2016 · 35 citations · 20 references
MedicineEndocrinologyMolecular BiologyGene ExpressionMetabolic RegulationTranscriptional RegulationDiabetes MellitusGlucose HomeostasisInsulin ResistanceInsulin Signaling In MetabolismMetabolic SignalingMetabolic SyndromeGlucose Metabolism DisordersHepatic Insulin ResistanceImpaired Insulin SensitivityInsulin MetabolismInsulin SensitizationInsulin Signaling PathwayLiver Insulin SignalingTransforming Growth Factor-beta Signaling
Obesity-related insulin resistance represents the core component of the metabolic syndrome, promoting glucose intolerance, pancreatic beta cell failure and type 2 diabetes. Efficient and safe insulin sensitization and glucose control remain critical therapeutic aims to prevent diabetic late complications Here, we identify transforming growth factor beta-like stimulated clone (TSC) 22 D4 as a molecular determinant of insulin signalling and glucose handling. Hepatic TSC22D4 inhibition both prevents and reverses hyperglycaemia, glucose intolerance and insulin resistance in diabetes mouse models. TSC22D4 exerts its effects on systemic glucose homeostasis-at least in part-through the direct transcriptional regulation of the small secretory protein lipocalin 13 (LCN13). Human diabetic patients display elevated hepatic TSC22D4 expression, which correlates with decreased insulin sensitivity, hyperglycaemia and LCN13 serum levels. Our results establish TSC22D4 as a checkpoint in systemic glucose metabolism in both mice and humans, and propose TSC22D4 inhibition as an insulin sensitizing option in diabetes therapy.
20
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
Dos D. Sarbassov, David A. Guertin, Siraj M. Ali et al. · Science · 2005 · 6.2K citations
Nora Klöting, Arne Dietrich, Péter Kovács et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 851 citations
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
Christian Rommel, Brian Clarke, Sven Zimmermann et al. · Science · 1999 · 768 citations
CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ
Stephan Herzig, Susan Hedrick, Ianessa Morantte et al. · Nature · 2003 · 320 citations